Levofloxacin

Details

Files

Generic Name:

Levofloxacin

Project Status:

Complete

Therapeutic Area:

Cystic fibrosis with chronic pulmonary Pseudomonas aeruginosa infections

Manufacturer:

Raptor Pharmaceuticals Inc.

Call for patient/clinician input open:

May 2, 2016

Brand Name:

Quinsair

Project Line:

Reimbursement Review

Project Number:

SR0493-000

Call for patient/clinician input closed:

June 21, 2016

NOC Status at Filing:

Post NOC

Performance Metric:

Achieved

Submission Type:

Initial

Indications:

Cystic fibrosis with chronic pulmonary Pseudomonas aeruginosa infections

Recommendation Type:

Reimburse with clinical criteria and/or conditions

Final Recommendation:

November 21, 2016

Last Updated : May 2, 2016